Home > Insider Trading > Filing (0000899243-19-004317)

Filing Details

Accession Number:: 0000899243-19-004317
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-02-20 19:48:32
Reporting Period:: 2018-11-19

Accepted Time:: 2019-02-20 19:48:32
Original Submission Date:: 2018-11-21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367644	Emergent Biosolutions Inc.	EBS	Pharmaceutical Preparations (2834)	141902018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380185	Fuad El-Hibri	400 Professional Drive, Suite 400 Gaithersburg MD 20879	Chairman	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-11-19	20,000	$14.44	1,508,675	No	4	M	Direct
Common Stock	Acquisiton	2018-11-20	15,173	$14.44	1,503,848	No	4	M	Direct
Common Stock	Acquisiton	2018-11-26	25,000	$13.38	1,513,675	No	4	M	Direct
Common Stock	Acquisiton	2018-11-27	20,832	$13.38	1,509,507	No	4	M	Direct
Common Stock	Disposition	2018-11-27	20,832	$69.59	1,488,675	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Options (Right to Buy)	Disposition	2018-11-19	20,000	$0.00	20,000	$14.44
Common Stock	Employee Stock Options (Right to Buy)	Disposition	2018-11-20	15,173	$0.00	15,173	$14.44
Common Stock	Employee Stock Options (Right to Buy)	Disposition	2018-11-26	25,000	$0.00	25,000	$13.38
Common Stock	Employee Stock Options (Right to Buy)	Disposition	2018-11-27	20,832	$0.00	20,832	$13.38

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,173	2019-03-12	No	4	M	Direct
0	2019-03-12	No	4	M	Direct
20,832	2020-03-11	No	4	M	Direct
0	2020-03-11	No	4	M	Direct

Footnotes

All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on June 6, 2018 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
The reported option exercises were inadvertently omitted from the original Form 4 filed with the Securities and Exchange Commission ("SEC") on November 21, 2018, which reported the sales of shares of the Issuer's common stock ("Common Stock") only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises.
The number of shares of Common Stock directly beneficially owned by the Reporting Person reported on this amended Form 4 gives effect to the sales of Common Stock by the Reporting Person as reported on the Forms 4 filed with the SEC on November 21, 2018 and November 28, 2018, as applicable.
The reported option exercises were inadvertently omitted from the original Form 4 filed with the SEC on November 28, 2018, which reported the sales of shares of Common Stock only, rather than the exercises of the options and subsequent sales of the shares of Common Stock acquired upon such exercises.
The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.31 to $70.32.
The options vested in three equal installments on March 12, 2013, March 12, 2014 and March 12, 2015.
The options vested in three equal installments on March 11, 2014, March 11, 2015 and March 11, 2016.